AbbVie to Host Virtual Immunology Strategic Update

Rhea-AI Summary

AbbVie will conduct a virtual immunology strategic update for investors on December 14, 2020, at 9:00 a.m. Central time. Richard A. Gonzalez, CEO, alongside the executive leadership team, will discuss AbbVie's immunology business and pipeline. Investors can access a live audio webcast on AbbVie's Investor Relations site, with an archived version available later that day. AbbVie's mission focuses on developing innovative medicines across various therapeutic areas, including immunology, oncology, and more.

NORTH CHICAGO, Ill., Dec. 1, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time. Richard A. Gonzalez, chairman of the board and chief executive officer, and members of the executive leadership team will present on AbbVie's immunology business and pipeline.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the webcast will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-virtual-immunology-strategic-update-301181943.html

SOURCE AbbVie

FAQ

When is AbbVie's virtual immunology update scheduled?

AbbVie's virtual immunology strategic update is on December 14, 2020, at 9:00 a.m. Central time.

Who will present at the AbbVie immunology update?

Richard A. Gonzalez, CEO, and AbbVie's executive leadership team will present at the update.

How can investors access the AbbVie immunology update?

Investors can access the live audio webcast on AbbVie's Investor Relations website.

Will there be a recording of the AbbVie immunology update?

Yes, an archived version of the webcast will be available later on December 14, 2020.

What are the key therapeutic areas AbbVie focuses on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.